Back

Comparative Evaluation of Adeno-Associated Virus and Lentivirus Mediated Gene Transfer in Adult Rat Optic Nerve

Kinane, C.; Koilkonda, R.; Gomez, J.; Khuu, T.; Talla, V.; Panchal, M.; Park, K. K.

2026-05-14 neuroscience
10.64898/2026.05.12.724624 bioRxiv
Show abstract

BackgroundThe optic nerve serves as a vital conduit for visual signaling, and its degeneration in optic neuropathy results in irreversible vision loss. It is also a widely used model for studying central nervous system (CNS) injury and repair. Although adeno-associated virus (AAV) and lentivirus are extensively applied in CNS research, their transduction efficiency and cell-type specificity within the optic nerve remain poorly characterized. This study aimed to identify the most effective viral vector, serotype, and promoter for direct gene delivery to the adult rat optic nerve. MethodsSprague-Dawley rats (7-10 weeks) received intra-optic nerve injections of lentiviral or AAV vectors encoding GFP under different promoters (CAG, CMV, or GFAP). Two to three weeks post-injection, optic nerves were collected for immunohistochemistry with markers of oligodendrocytes (Olig2), astrocytes (GFAP, Sox9), and microglia (IBA1). Transduction efficiency and cell-type specificity were assessed using confocal microscopy. ResultsAAV2, AAV5, and lentivirus showed minimal transduction, with only sparse GFP-positive cells observed near injection sites. In contrast, AAV-PHP.eB carrying the CAG promoter yielded robust and widespread GFP expression near the injection site. Quantitative analysis revealed that approximately 90% of transduced cells were Olig2-positive oligodendrocytes, indicating strong tropism for this glial population. ConclusionAAV-PHP.eB driven by the CAG promoter enables efficient gene delivery to the optic nerve, with a predominant tropism for oligodendrocytes. This targeted intra-optic nerve injection approach offers a reliable platform for manipulating oligodendrocytes and investigating mechanisms of CNS development, injury, and repair relevant to both optic neuropathies and other CNS diseases.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 8%
19.3%
2
Scientific Reports
3102 papers in training set
Top 11%
7.4%
3
Journal of Neuroscience Methods
106 papers in training set
Top 0.2%
6.6%
4
Translational Vision Science & Technology
35 papers in training set
Top 0.2%
5.0%
5
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.1%
4.5%
6
Frontiers in Neurology
91 papers in training set
Top 1%
4.1%
7
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.1%
3.7%
50% of probability mass above
8
eneuro
389 papers in training set
Top 3%
3.2%
9
Journal of Translational Medicine
46 papers in training set
Top 0.4%
2.5%
10
Journal of Comparative Neurology
66 papers in training set
Top 0.3%
1.9%
11
Current Protocols
13 papers in training set
Top 0.1%
1.9%
12
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.6%
1.4%
13
Frontiers in Neuroanatomy
14 papers in training set
Top 0.1%
1.4%
14
Biochemical and Biophysical Research Communications
78 papers in training set
Top 1%
0.8%
15
Neuroscience
88 papers in training set
Top 2%
0.8%
16
ACS Chemical Neuroscience
60 papers in training set
Top 2%
0.8%
17
Clinical and Translational Science
21 papers in training set
Top 1.0%
0.8%
18
Archives of Clinical and Biomedical Research
28 papers in training set
Top 3%
0.7%
19
Journal of Medical Virology
137 papers in training set
Top 5%
0.7%
20
eBioMedicine
130 papers in training set
Top 5%
0.7%
21
Frontiers in Neuroscience
223 papers in training set
Top 8%
0.7%
22
Frontiers in Medicine
113 papers in training set
Top 7%
0.7%
23
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
0.7%
24
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.7%
0.7%
25
Wellcome Open Research
57 papers in training set
Top 2%
0.7%
26
BMJ Open
554 papers in training set
Top 14%
0.5%
27
Neuroscience Letters
28 papers in training set
Top 2%
0.5%
28
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.5%
29
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 4%
0.5%
30
Fluids and Barriers of the CNS
21 papers in training set
Top 0.5%
0.5%